Madrigal Pharmaceuticals Inc Asset Turnover Ratio (MDGL), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Madrigal Pharmaceuticals Inc   (NASDAQ: MDGL)
 

Madrigal Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Madrigal Pharmaceuticals Inc asset turnover ratio, the ability of Madrigal Pharmaceuticals Inc 's assets to generate revenue in the third quarter 2026, increased sequentially to 1.11 in the third quarter (Sep 30 2026), MDGL's balance sheet remain strong.

Within sector 23 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2026 compared to the preceding quarter from 1017 to 1069.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MDGL Asset Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Asset Change 5.74 % 23.34 % 23.41 % 20.66 % 26.74 %
Y / Y Revenue Change 50.13 % 71.17 % 126.84 % 210.77 % 362.03 %
Asset Turnover Ratio (TTM) 1.11 1.01 0.93 0.83 0.67
MDGL's Total Ranking # 1069 # 1017 # 511 # 1503 #
Seq. Asset Change 15.25 % 1.45 % -2.18 % -7.55 % 34.43 %
Seq. Revenue Change 18.4 % 17 % -3.04 % 11.77 % 34.99 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 24
Healthcare Sector # 103
Overall Market # 1069

Asset Turnover Ratio Statistics
High Average Low
1.01 0.71 0.3
(Jun 30 2026)   (Mar 31 2025)




MDGL Company Profile • Back to MDGL Efficiency Comparisons • Compare MDGL Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Assets at quarter ending Sep 30 2026
Healthcare Services Group Inc   2.29 $ 1,879.860  Millions$ 820.088  Millions
Innovage Holding Corp   1.86 $ 1,018.359  Millions$ 548.808  Millions
Avita Medical Inc   1.67 $ 84.683  Millions$ 50.627  Millions
Chemed Corporation  1.67 $ 2,661.041  Millions$ 1,593.007  Millions
Koru Medical Systems Inc   1.63 $ 46.272  Millions$ 28.385  Millions
Brightspring Health Services Inc   1.52 $ 9,479.144  Millions$ 6,219.741  Millions
Sonoma Pharmaceuticals Inc   1.50 $ 23.490  Millions$ 15.698  Millions
Medinotec Inc   1.48 $ 10.211  Millions$ 6.890  Millions
Idexx Laboratories Inc  1.34 $ 4,663.675  Millions$ 3,471.425  Millions
Medpace Holdings Inc   1.34 $ 2,838.385  Millions$ 2,116.215  Millions
Exagen Inc   1.34 $ 72.769  Millions$ 54.317  Millions
Edap Tms Sa  1.32 $ 111.370  Millions$ 84.080  Millions
Myomo Inc   1.32 $ 47.775  Millions$ 36.134  Millions
Precipio inc   1.30 $ 27.762  Millions$ 21.289  Millions
Liquidia Corporation  1.29 $ 621.865  Millions$ 483.582  Millions
Tactile Systems Technology Inc   1.28 $ 357.176  Millions$ 279.255  Millions
Hca Healthcare Inc   1.26 $ 78,701.000  Millions$ 62,218.000  Millions
Electromed Inc   1.23 $ 74.561  Millions$ 60.436  Millions
Angiodynamics Inc   1.23 $ 323.784  Millions$ 262.480  Millions
Tela Bio Inc   1.22 $ 79.525  Millions$ 65.135  Millions
Henry Schein Inc   1.21 $ 13,734.000  Millions$ 11,352.500  Millions
Tarsus Pharmaceuticals Inc   1.21 $ 682.203  Millions$ 564.984  Millions
Harvard Bioscience Inc   1.17 $ 90.339  Millions$ 77.399  Millions
Axsome Therapeutics Inc   1.16 $ 865.268  Millions$ 747.908  Millions
Sanuwave Health Inc   1.14 $ 41.031  Millions$ 35.892  Millions
Ironwood Pharmaceuticals inc   1.14 $ 400.296  Millions$ 351.797  Millions
Biodesix Inc   1.13 $ 105.212  Millions$ 92.846  Millions
Indivior Pharmaceuticals Inc   1.11 $ 1,376.000  Millions$ 1,240.750  Millions
Pro dex Inc   1.11 $ 79.578  Millions$ 71.817  Millions
Madrigal Pharmaceuticals Inc   1.11 $ 1,427.940  Millions$ 1,291.488  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.